Peter Pongratz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Peter Pongratz has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Benjamin Mordmüller
Radboudumc Afdeling Medische Microbiologie, Nijmegen, Gelderland, The Netherlands
1 shared publication Christoph Wenisch
Sozialmedizinisches Zentrum Süd – Kaiser-Franz-Josef Hospital
1 shared publication- Florian Kurth
Department of Infectious Diseases and Critical Care Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
1 shared publication Gerold Stanek
Medical University of Vienna
1 shared publicationGünther Strau
Sozialmedizinisches Zentrum Süd – Kaiser-Franz-Josef Hospital
1 shared publicationHermann Laferl
Sozialmedizinisches Zentrum Süd – Kaiser-Franz-Josef Hospital
1 shared publication
Latest Publications
- 26 October 2012
- Published by Springer Nature in Wiener klinische Wochenschrift
- Vol. 124 (3) , 35-38
Coughing and fever after surfing in Central America
- 26 October 2012
- Published by Springer Nature in Wiener klinische Wochenschrift
- Vol. 124 (3) , 35-38
Coughing and fever after surfing in Central America
- Open Access
- 23 April 2009
- Published by Springer Nature in Malaria Journal
- Vol. 8 (1) , 79
In vitro activity of pyronaridine against Plasmodium falciparum and comparative evaluation of anti-malarial drug susceptibility assays
Pyronaridine, a Mannich base anti-malarial with high efficacy against drug resistant Plasmodium falciparum, is currently evaluated as a fixed dose combination with artesunate for the treatment of uncomplicated malaria. In this study, the in vitro activity of pyronaridine against clinical isolates of P. falciparum from Lambaréné, Gabon, was assessed in order to obtain baseline data on its activity prior to its future use in routine therapy. Moreover, follow-up assessment on the in vitro activity of chloroquine, artesunate and quinine was performed.
- 23 April 2009
- Published by Springer Nature in Malaria Journal
- Vol. 8 (1) , 79
Open AccessIn vitro activity of pyronaridine against Plasmodium falciparum and comparative evaluation of anti-malarial drug susceptibility assays
Pyronaridine, a Mannich base anti-malarial with high efficacy against drug resistant Plasmodium falciparum, is currently evaluated as a fixed dose combination with artesunate for the treatment of uncomplicated malaria. In this study, the in vitro activity of pyronaridine against clinical isolates of P. falciparum from Lambaréné, Gabon, was assessed in order to obtain baseline data on its activity prior to its future use in routine therapy. Moreover, follow-up assessment on the in vitro activity of chloroquine, artesunate and quinine was performed.